ID

31668

Beschreibung

A Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate Tumors; ODM derived from: https://clinicaltrials.gov/show/NCT02225262

Link

https://clinicaltrials.gov/show/NCT02225262

Stichworte

Versionen (2)
  1. 18.09.18 18.09.18 -
  2. 18.09.18 18.09.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

18. September 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Prostate Cancer NCT02225262

Englisch

Eligibility Prostate Cancer NCT02225262

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
male age ≥ 21
Beschreibung

Gender | Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
histologically proven prostate adenocarcinoma
Beschreibung

Adenocarcinoma of prostate

Datentyp

boolean

Alias
UMLS CUI [1]
C0007112
clinical stage t1b-t2b, n0-nx, m0-mx (ajcc 6th edition)
Beschreibung

TNM clinical staging

Datentyp

boolean

Alias
UMLS CUI [1]
C3258246
psa ≤ 20 ng/ml
Beschreibung

Prostate specific antigen measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0201544
prostate volume ≤ 100 cc
Beschreibung

Prostate volume

Datentyp

boolean

Alias
UMLS CUI [1]
C1441416
patients belonging in one of the following risk groups:
Beschreibung

Risk Groups

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0035647
UMLS CUI [1,2]
C0441833
low:
Beschreibung

Low Risk

Datentyp

boolean

Alias
UMLS CUI [1]
C3538919
cs t1b-t2a and gleason 2-6 and psa ≤ 10
Beschreibung

TNM clinical staging | Gleason score | Prostate specific antigen measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C3258246
UMLS CUI [2]
C3203027
UMLS CUI [3]
C0201544
intermediate:
Beschreibung

Intermediate Risk

Datentyp

boolean

Alias
UMLS CUI [1]
C3640764
cs t2b and gleason 2-6 and psa ≤ 10, or
Beschreibung

TNM clinical staging | Gleason score | Prostate specific antigen measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C3258246
UMLS CUI [2]
C3203027
UMLS CUI [3]
C0201544
cs t1b-t2b, and gleason 2-6 and psa ≤ 20 ng/ml or gleason 7 and psa ≤ 10 ng/ml
Beschreibung

TNM clinical staging | Gleason score | Prostate specific antigen measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C3258246
UMLS CUI [2]
C3203027
UMLS CUI [3]
C0201544
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
any histology other than adenocarcinoma
Beschreibung

Histology Any | Exception Adenocarcinoma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0344441
UMLS CUI [1,2]
C1552551
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0001418
age < 21
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
kps <= 40 <70
Beschreibung

Karnofsky Performance Status

Datentyp

boolean

Alias
UMLS CUI [1]
C0206065
ecog performance status ≥ 2
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
patient weight >350 lbs. (table limitation)
Beschreibung

Body Weight

Datentyp

boolean

Alias
UMLS CUI [1]
C0005910
prior xrt to prostate or lower pelvis
Beschreibung

Prostate external beam radiation therapy | External Radiation Therapy Pelvis Lower

Datentyp

boolean

Alias
UMLS CUI [1]
C0860348
UMLS CUI [2,1]
C1517033
UMLS CUI [2,2]
C0030797
UMLS CUI [2,3]
C0441994
prior surgery or cryotherapy to prostate
Beschreibung

Operation on prostate | Cryotherapy of prostate

Datentyp

boolean

Alias
UMLS CUI [1]
C0194790
UMLS CUI [2]
C3544233
implanted hardware or other material that would prohibit appropriate treatment planning or treatment delivery, in the investigator's opinion
Beschreibung

Materials Implanted Preventing Treatment Plan | Materials Implanted Preventing Therapeutic procedure

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0520510
UMLS CUI [1,2]
C0021102
UMLS CUI [1,3]
C1292733
UMLS CUI [1,4]
C0599880
UMLS CUI [2,1]
C0520510
UMLS CUI [2,2]
C0021102
UMLS CUI [2,3]
C1292733
UMLS CUI [2,4]
C0087111
chemotherapy for a malignancy in the last 5 years
Beschreibung

Chemotherapy Malignant Neoplasms

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0006826
history of an invasive malignancy (other than this prostate cancer, or basal or squamous skin cancers) in the last 5 years
Beschreibung

Invasive cancer | Exception Prostate carcinoma | Exception Basal cell carcinoma | Exception Squamous cell carcinoma of skin

Datentyp

boolean

Alias
UMLS CUI [1]
C0677898
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0600139
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0007117
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0553723
hormone ablation for 2 months prior to enrollment, or during treatment
Beschreibung

Antiandrogen therapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0279492
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Prostate Cancer NCT02225262

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Age
Item
male age ≥ 21
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Adenocarcinoma of prostate
Item
histologically proven prostate adenocarcinoma
boolean
C0007112 (UMLS CUI [1])
TNM clinical staging
Item
clinical stage t1b-t2b, n0-nx, m0-mx (ajcc 6th edition)
boolean
C3258246 (UMLS CUI [1])
Prostate specific antigen measurement
Item
psa ≤ 20 ng/ml
boolean
C0201544 (UMLS CUI [1])
Prostate volume
Item
prostate volume ≤ 100 cc
boolean
C1441416 (UMLS CUI [1])
Risk Groups
Item
patients belonging in one of the following risk groups:
boolean
C0035647 (UMLS CUI [1,1])
C0441833 (UMLS CUI [1,2])
Low Risk
Item
low:
boolean
C3538919 (UMLS CUI [1])
TNM clinical staging | Gleason score | Prostate specific antigen measurement
Item
cs t1b-t2a and gleason 2-6 and psa ≤ 10
boolean
C3258246 (UMLS CUI [1])
C3203027 (UMLS CUI [2])
C0201544 (UMLS CUI [3])
Intermediate Risk
Item
intermediate:
boolean
C3640764 (UMLS CUI [1])
TNM clinical staging | Gleason score | Prostate specific antigen measurement
Item
cs t2b and gleason 2-6 and psa ≤ 10, or
boolean
C3258246 (UMLS CUI [1])
C3203027 (UMLS CUI [2])
C0201544 (UMLS CUI [3])
TNM clinical staging | Gleason score | Prostate specific antigen measurement
Item
cs t1b-t2b, and gleason 2-6 and psa ≤ 20 ng/ml or gleason 7 and psa ≤ 10 ng/ml
boolean
C3258246 (UMLS CUI [1])
C3203027 (UMLS CUI [2])
C0201544 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Histology Any | Exception Adenocarcinoma
Item
any histology other than adenocarcinoma
boolean
C0344441 (UMLS CUI [1,1])
C1552551 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0001418 (UMLS CUI [2,2])
Age
Item
age < 21
boolean
C0001779 (UMLS CUI [1])
Karnofsky Performance Status
Item
kps <= 40 <70
boolean
C0206065 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status ≥ 2
boolean
C1520224 (UMLS CUI [1])
Body Weight
Item
patient weight >350 lbs. (table limitation)
boolean
C0005910 (UMLS CUI [1])
Prostate external beam radiation therapy | External Radiation Therapy Pelvis Lower
Item
prior xrt to prostate or lower pelvis
boolean
C0860348 (UMLS CUI [1])
C1517033 (UMLS CUI [2,1])
C0030797 (UMLS CUI [2,2])
C0441994 (UMLS CUI [2,3])
Operation on prostate | Cryotherapy of prostate
Item
prior surgery or cryotherapy to prostate
boolean
C0194790 (UMLS CUI [1])
C3544233 (UMLS CUI [2])
Materials Implanted Preventing Treatment Plan | Materials Implanted Preventing Therapeutic procedure
Item
implanted hardware or other material that would prohibit appropriate treatment planning or treatment delivery, in the investigator's opinion
boolean
C0520510 (UMLS CUI [1,1])
C0021102 (UMLS CUI [1,2])
C1292733 (UMLS CUI [1,3])
C0599880 (UMLS CUI [1,4])
C0520510 (UMLS CUI [2,1])
C0021102 (UMLS CUI [2,2])
C1292733 (UMLS CUI [2,3])
C0087111 (UMLS CUI [2,4])
Chemotherapy Malignant Neoplasms
Item
chemotherapy for a malignancy in the last 5 years
boolean
C0392920 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
Invasive cancer | Exception Prostate carcinoma | Exception Basal cell carcinoma | Exception Squamous cell carcinoma of skin
Item
history of an invasive malignancy (other than this prostate cancer, or basal or squamous skin cancers) in the last 5 years
boolean
C0677898 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0600139 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0007117 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0553723 (UMLS CUI [4,2])
Antiandrogen therapy
Item
hormone ablation for 2 months prior to enrollment, or during treatment
boolean
C0279492 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video